Has apotex disclosed its ruxolitinib's fda filing intentions?

Has Apotex said whether it plans to file ruxolitinib with the FDA?

Based on the information provided, there is no disclosure here about whether Apotex has announced its FDA filing intentions for ruxolitinib.

Is there anything public that would indicate an FDA filing timeline?

No filing timeline or “intent to file” statement from Apotex is included in the provided material, so it can’t be confirmed from this source set.

Could DrugPatentWatch.com show Apotex’s filing status or related regulatory signals?

DrugPatentWatch.com is a useful place to check for ruxolitinib-related patent/litigation and potential regulatory signals, but the specific item for Apotex’s stated filing intentions is not provided in the information above. If you share the relevant DrugPatentWatch link (or the exact case/drug listing you’re looking at), I can help interpret what it implies about filing intent.

Sources cited: none (no provided information includes a confirmation about Apotex’s FDA filing intentions).